HK182096A - Novel calcium supplements - Google Patents

Novel calcium supplements

Info

Publication number
HK182096A
HK182096A HK182096A HK182096A HK182096A HK 182096 A HK182096 A HK 182096A HK 182096 A HK182096 A HK 182096A HK 182096 A HK182096 A HK 182096A HK 182096 A HK182096 A HK 182096A
Authority
HK
Hong Kong
Prior art keywords
calcium supplements
novel calcium
malate
calcium
citrate
Prior art date
Application number
HK182096A
Other languages
English (en)
Inventor
Stephen Allen Jacobs
Original Assignee
Norwich Eaton Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Norwich Eaton Pharma filed Critical Norwich Eaton Pharma
Publication of HK182096A publication Critical patent/HK182096A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/235—Saturated compounds containing more than one carboxyl group
    • C07C59/245—Saturated compounds containing more than one carboxyl group containing hydroxy or O-metal groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/235—Saturated compounds containing more than one carboxyl group
    • C07C59/245—Saturated compounds containing more than one carboxyl group containing hydroxy or O-metal groups
    • C07C59/265—Citric acid

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Diabetes (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
HK182096A 1987-08-28 1996-10-03 Novel calcium supplements HK182096A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US9081387A 1987-08-28 1987-08-28

Publications (1)

Publication Number Publication Date
HK182096A true HK182096A (en) 1996-10-11

Family

ID=22224448

Family Applications (1)

Application Number Title Priority Date Filing Date
HK182096A HK182096A (en) 1987-08-28 1996-10-03 Novel calcium supplements

Country Status (13)

Country Link
EP (1) EP0304987B1 (ko)
JP (1) JP2795651B2 (ko)
KR (1) KR970009583B1 (ko)
AT (1) ATE82120T1 (ko)
AU (1) AU625809B2 (ko)
CA (1) CA1314233C (ko)
DE (1) DE3875867T2 (ko)
DK (1) DK481388A (ko)
HK (1) HK182096A (ko)
IE (1) IE61452B1 (ko)
IL (1) IL87452A (ko)
NZ (1) NZ225950A (ko)
ZA (1) ZA886355B (ko)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0533724B1 (en) * 1990-06-14 1995-04-26 The Procter & Gamble Company Calcium citrate malate composition
CA2102210C (en) * 1991-05-06 1998-08-04 Mark Benson Andon Combined calcium and vitamin d supplements
EP0622992B1 (en) * 1991-12-26 1998-10-14 The Procter & Gamble Company Storage stable calcium-supplemented beverage concentrates
US5389387A (en) * 1991-12-26 1995-02-14 The Procter & Gamble Company Storage stable calcium-supplemented beverage concentrates
CA2146632C (en) * 1992-10-21 1999-02-23 Alice Lyles Burkes Sweetener containing a concentrated bioavailable calcium source
CA2146633C (en) * 1992-10-21 1998-09-01 Mark Benson Andon Concentrated bioavailable calcium source
ES2089858T3 (es) * 1992-10-21 1996-10-01 Procter & Gamble Concentrados de premezcla para bebidas suplementados con calcio y estables en almacenamiento.
IL115241A (en) * 1994-09-26 2000-08-31 American Cyanamid Co Calcium dietary supplement
JPH09173020A (ja) * 1995-12-28 1997-07-08 Shiro Tanaka クエン酸・リンゴ酸カルシウムの可溶性濃厚カルシウム凍結品／冷蔵品およびその製造法
CN101505730B (zh) * 2006-08-17 2013-02-13 宝洁公司 包含柠檬酸苹果酸钙的组合物以及它们的制备方法
JP5140669B2 (ja) * 2006-08-17 2013-02-06 ザ プロクター アンド ギャンブル カンパニー クエン酸リンゴ酸カルシウムを含む組成物及びその製造方法
TR200908237A2 (tr) 2009-11-02 2011-05-23 Bi̇lgi̇ç Mahmut Kalsiyum ve D vitamini içeren farmasötik bileşimler.
CN104114179A (zh) * 2011-12-13 2014-10-22 艾玛菲克有限公司 用于治疗钙吸收不良和骨代谢紊乱的无定形碳酸钙
CN107921060A (zh) 2015-06-04 2018-04-17 艾玛菲克有限公司 用于吸入施用、舌下施用或含服施用的无定形碳酸钙的组合物
IL294615A (en) 2016-10-25 2022-09-01 Amorphical Ltd Amorphous calcium carbonate for the treatment of leukemia
CN112137787B (zh) * 2020-09-16 2023-01-06 张宏伟 一种足踝外科下胫腓关节复位固定导向器

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5697248A (en) * 1979-12-28 1981-08-05 Tanaka Shiro Conjugated compound of calcium citrate and calcium malate and its preparation
FR2601249A1 (fr) * 1986-07-09 1988-01-15 Sandoz Lab Nouvelles compositions pharmaceutiques a base de sels de calcium.
US4786510A (en) * 1987-07-02 1988-11-22 The Procter & Gamble Company Calcium-iron mineral supplements
CA1319612C (en) * 1987-07-02 1993-06-29 Haile Mehansho Iron-calcium mineral supplements with enhanced bioavailability

Also Published As

Publication number Publication date
DE3875867D1 (de) 1992-12-17
KR970009583B1 (en) 1997-06-14
DE3875867T2 (de) 1993-04-01
ATE82120T1 (de) 1992-11-15
IE882610L (en) 1989-02-28
EP0304987A2 (en) 1989-03-01
CA1314233C (en) 1993-03-09
EP0304987A3 (en) 1990-02-21
JPH01156985A (ja) 1989-06-20
IE61452B1 (en) 1994-11-02
KR890003391A (ko) 1989-04-14
ZA886355B (en) 1989-05-30
AU625809B2 (en) 1992-07-16
EP0304987B1 (en) 1992-11-11
NZ225950A (en) 1991-10-25
DK481388A (da) 1989-03-02
AU2159888A (en) 1989-06-15
JP2795651B2 (ja) 1998-09-10
DK481388D0 (da) 1988-08-29
IL87452A0 (en) 1989-01-31
IL87452A (en) 1992-07-15

Similar Documents

Publication Publication Date Title
KR970009583B1 (en) Calcium supplements
IL84425A (en) (s) - (+) -ibuprofen-containing pharmaceutical compositions
IL83510A (en) Pharmaceutical compositions containing dipyridamole or mopidamol and o-acetylsalicylic acid or salts thereof and their preparation
EP0449247A3 (en) Pharmaceutical composition containing galanthamine for treating alcoholism
PT85829A (en) Therapeutic agents
ZA927157B (en) Medicaments for treating gastrointestinal disorders.
NZ232946A (en) Preparation of crystalline 17alpha-hydroxy-7alpha methyl-19-nor-17-pregn-5
ES2026304A6 (es) Procedimiento de fabricacion de una forma de dosificacion de nicardipina.
KR970009582B1 (en) Method for the treatment of oste oporosis and related disorders
EP0221728A3 (en) Monosaccharide containing wound healing preparation
PT86205A (en) Process for the preparation of 3-]omega-(3,5-di-t-butil-4-hydroxyphenyl)-alkanoyl"pyrroles and their de-oxy analogs useful in therapy
IT1215332B (it) Composizione farmaceutica contenente sulglicotide per la terapia dell'ulcera gastrica
ZA885372B (en) Nutrieut mixture intended for the elderly
DE3766885D1 (en) Chlorpheniramine therapie.
EP0316709A3 (en) Proteinaceous derivatives containing iron in highly bioaproteinaceous derivatives containing iron in highly bioavailable form, preparation thereof and pharmaceutical covailable form, preparation thereof and pharmaceutical compositions containing them mpositions containing them
IL79207A0 (en) Pharmaceutical compositions containing terguide
IL80976A0 (en) 4-thienyl-dihydropyridines,their preparation and pharmaceutical compositions containing them
DE3786168D1 (de) Verwendung von para-aminobenzoesaeure zur herstellung eines arzneimittels zur bekaempfung von photoallergien.

Legal Events

Date Code Title Description
PF Patent in force
PE Patent expired

Effective date: 20080814